Herceptin

Company: Genentech
Approval Status: Approved October 1998
Treatment for: Breast cancer
Areas: Diabetes / Endocrinology; Pregnancy & Gynecology; Cancer & Oncology
Possible similar drugs: Herceptin

| General Information |

General Information

Herceptin (trastuzumab) is used as a second- or third-line therapy for patients with metastatic breast cancer.

< back to top

Herceptin Drug Information

The Herceptin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.